immunomodulation

Type: Keyphrase
Name: immunomodulation
First reported 16 hours ago - Updated 8 hours ago - 1 reports

Sanford-Burnham Appoints Perry Nisen as Chief Executive Officer

SOURCE: Sanford-Burnham Medical Research InstituteDr. Nisen Will Lead the Implementation of Sanford-Burnham's New 10-Year Strategic Vision and Expand the Institute's Therapeutics Discovery EffortsLA JOLLA, CA --(Marketwired - August 19, 2014) - Sanford-Burnham ... [Published MarketWired - 16 hours ago]
First reported Aug 18 2014 - Updated 22 hours ago - 1 reports

Pigs' hearts transplanted into baboon hosts remain viable more than a year

Investigators from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) have successfully transplanted hearts from genetically engineered piglets into baboons' abdomens and had the hearts survive for more than ... [Published Medical Xpress - Aug 18 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

Global Tissue Engineering and Regeneration Market to Reach $56.9 Billion in 2019

BCC Research reveals in its new report, Tissue Engineering and Regeneration: Technologies and Global Markets , the global market for tissue engineering and regeneration is expected to grow to $56.9 billion by 2019, with a five-year compound annual growth ... [Published Medical Design Technology - Aug 18 2014]
First reported Aug 16 2014 - Updated Aug 16 2014 - 1 reports

Enriching Feeding Tube Nutrition may Increase ...

Providing high protein nutrition diet through a feeding tube enriched with immune-modulating nutrients, such as glutamine, omega-3 fatty acids, and antioxidants, for mechanically ventilated patients in intensive care units (ICU) provides no significant ... [Published MedIndia - Aug 16 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Mesalazine in the initial management of severely acutely malnourished children with environmental ...

Environmental enteric dysfunction (EED) is an acquired syndrome of impaired gastrointestinal mucosal barrier function that is thought to play a key role in the pathogenesis of stunting in early life. It has been conceptualized as an adaptive response ... [Published 7thSpace - Aug 14 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

New Immunotherapy Findings from V.M. Subbotin et al Outlined (Dendritic cell-based cancer immunotherapy: the stagnant approach and a theoretical...

New Immunotherapy Findings from V.M. Subbotin et al Outlined (Dendritic cell-based cancer immunotherapy: the stagnant approach and a theoretical solution)By a News Reporter-Staff News Editor at Drug Week -- Current study results on Biotechnology have ... [Published HispanicBusiness.com - Aug 14 2014]
First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

[Editorial] Skin cancer: prevention is better than cure

Skin cancer is now the most commonly diagnosed cancer in the USA with about 5 million people treated every year. In Germany, the Federal Statistics Bureau reported last week that treatment for skin cancer in hospital has risen more than that for any other ... [Published The Lancet - Aug 08 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

Researchers seek 'safety lock' against tumor growth after stem cell transplantation

Putnam Valley, NY. (Aug. 6, 2014) Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates. However, a serious ... [Published Bio-Medicine - Aug 06 2014]
First reported Aug 05 2014 - Updated Aug 06 2014 - 2 reports

No Benefit, Possible Harm With Immunonutrition in ICU Patients

NEW YORK (Reuters Health) - Adding immune-modulating nutrients to high-protein enteral nutrition does not help stave off infections in mechanically ventilated adults in the intensive care unit, new research shows.By contrast, patients given immunonutrition ... [Published General Medicine eJournal - Aug 06 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Researchers Submit Patent Application, "Therapeutic Compounds for Immunomodulation", for Approval

By a News Reporter-Staff News Editor at Cancer Vaccine Week -- From Washington, D.C. , NewsRx journalists report that a patent application by the inventors Sasikumar, Pottayil G. N. (Bangalore, IN); Ramachandra, Muralidhara ( Bangalore , IN); Vadlamani, ... [Published HispanicBusiness.com - Jul 30 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Findings from University of California Provides New Data on Clinical Trials and Studies (Combinatorial Approach to Treatment of Melanoma)

By a News Reporter-Staff News Editor at Clinical Trials Week Current study results on Clinical Research have been published. According to news originating from San Francisco, California, by NewsRx correspondents, research stated, "There are multiple ... [Published Pharmacy Choice - Jul 28 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Tissue Engineering And Regeneration Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research

Tissue engineering and encompasses those products used in medicine. The application of these new age biomaterials include burn treatment or wound care, orthopaedics, urological products, and neurology products. Engineered cell growth has been present ... [Published MyNewsDesk - Jul 28 2014]

Quotes

"Sanford-Burnham has a legacy, culture, and environment that enable the unfettered conduct of some of the world's most high-impact, cutting-edge research. I'm passionately committed to translating that science into meaningful clinical results" said Dr. Nisen
More information: "Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation" by Muhammad M Mohiuddin, MD, Avneesh K Singh, PhD, Philip C Corcoran, MD, Robert F Hoyt, DVM, Marvin L Thomas III, DVM, David Ayares, PhD, and Keith...
...market is hampered due to stiff regulations, lack of awareness, and lack of adoption," says BCC Research healthcare analyst Yojana Jeevane. "And while the advancement in stem cell technologies has created a novel platform for regenerative medicines, it also has given rise to ethical issues. These ethical conflicts are putting pressure on the government to regulate the commercialization of tissue repair and regeneration."
"Are there specific critically ill populations that may benefit from some immunomodulation or supplementation of individual immunomodulating agents, such as glutamine supplementation in burns or vitamin D replacement in severe sepsis? Does administration of multiple potential immunologic modulating agents together alter the individual effects of each agent? Combined administration in a single formula or supplement in all of these trials prevents implicating any single component (i e., omega-3 fatty acids, glutamine, or antioxidants). In addition, enteral and parenteral [intravenous] administration may result in differential effects. Although these uses of immunomodulating nutrition still need to be explored, the similarity of the results and the suggestion of harm from recently published, large, randomized trials of immunonutrition should strongly discourage intensivists from its routine prescription for critically ill patients in clinical practice outside the scope of well-designed randomized clinical trials."

More Content

All (50) | News (42) | Reports (0) | Blogs (7) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Sanford-Burnham Appoints Perry Nisen as Chief E... [Published MarketWired - 16 hours ago]
Pigs' hearts transplanted into baboon hosts rem... [Published Medical Xpress - Aug 18 2014]
Global Tissue Engineering and Regeneration Mark... [Published Medical Design Technology - Aug 18 2014]
Enriching Feeding Tube Nutrition may Increase ... [Published MedIndia - Aug 16 2014]
Cord Blood Stem Cells and Regenerative Medicine [Published Research and Markets - Aug 15 2014]
Mesalazine in the initial management of severel... [Published 7thSpace - Aug 14 2014]
Agonists of neurotrophin receptors and their us... [Published PharmCast - Aug 14 2014]
New Immunotherapy Findings Reported from D.J. M... [Published HispanicBusiness.com - Aug 14 2014]
New Immunotherapy Findings from V.M. Subbotin e... [Published HispanicBusiness.com - Aug 14 2014]
Investigators from University of Strasbourg Rep... [Published HispanicBusiness.com - Aug 13 2014]
Shared Characteristics Between M. tuberculosis ... [Published General Medicine eJournal - Aug 12 2014]
Enriching Feeding Tube Nutrition may Increase R... [Published MedIndia - Aug 11 2014]
European CHMP Adopts Positive Opinion for Gilea... [Published Pharmacy Choice - Aug 11 2014]
[Editorial] Skin cancer: prevention is better t... [Published The Lancet - Aug 08 2014]
Findings on Immunotherapy Reported by Researche... [Published HispanicBusiness.com - Aug 06 2014]
Probiodrug Presents Pre-clinical and Clinical F... [Published HispanicBusiness.com - Aug 06 2014]
European CHMP Adopts Positive Opinion for Gilea... [Published HispanicBusiness.com - Aug 06 2014]
Incyte Announces Clinical Trial Agreement to Ev... [Published HispanicBusiness.com - Aug 06 2014]
New Non-Small Cell Lung Cancer Study Findings R... [Published HispanicBusiness.com - Aug 06 2014]
Researchers seek 'safety lock' against tumor gr... [Published Bio-Medicine - Aug 06 2014]
No Benefit, Possible Harm With Immunonutrition ... [Published General Medicine eJournal - Aug 06 2014]
Effect of enriching feeding tube nutrition on r... [Published Medical Xpress - Aug 05 2014]
Finding markers for inflammation and auto-immunity [Published Australian Life Scientist - Aug 05 2014]
Natural allopathic treatment modalities for Ebola [Published Sott.net - Aug 05 2014]
New Clinical Trials and Studies Study Results R... [Published Pharmacy Choice - Aug 04 2014]
Scientific guideline: Draft concept paper on gu... [Published EMA Ongoing public consultations - Aug 01 2014]
Research Conducted at University of Pennsylvani... [Published HispanicBusiness.com - Jul 31 2014]
Findings from Kyoto University in Immunotherapy... [Published HispanicBusiness.com - Jul 31 2014]
Researchers Submit Patent Application, "Therape... [Published HispanicBusiness.com - Jul 30 2014]
Batu Biologics' Lung Cancer Immunotherapy Featu... [Published Pharmacy Choice - Jul 30 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
[Editorial] Skin cancer: prevention is better t... [Published The Lancet - Aug 08 2014]
Skin cancer is now the most commonly diagnosed cancer in the USA with about 5 million people treated every year. In Germany, the Federal Statistics Bureau reported last week that treatment for skin cancer in hospital has risen more than that for any other ...
Qu Biologics to Present Crohn's Disease Compass... [Published Marketwire - Breaking News Releases - Apr 28 2014]
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 28, 2014) - Qu Biologics Inc ., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's immune system, announced that its abstract was selected for ...
Antibody Engineering & Therapeutics Call For Sp... [Published Future of BioPharma - Apr 22 2014]
The deadline for speaker abstract submissions for the Antibody Engineering & Therapeutics Event is Friday, April 25, 2014. To submit a proposal, you will be asked to select the conference topic you are interested in, provide a 100-150 word summary ...
Blocking B cells is not always good news for MS [Published Multiple Sclerosis Research - Mar 21 2014]
Kappos L, Hartung HP, Freedman MS, Boyko A, Radü EW, Mikol DD, Lamarine M, Hyvert Y, Freudensprung U, Plitz T, van Beek J; for the ATAMS Study Group.  Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial. ...
[Articles] Atacicept in multiple sclerosis (ATA... [Published The Lancet Neurology online - Mar 06 2014]
Increased clinical disease activity associated with atacicept suggests that the role of B cells and humoral immunity in multiple sclerosis is complex. For studies that explore therapeutic immunomodulation in multiple sclerosis, rigorous monitoring for ...
1 2

Press Releases

sort by: Date | Relevance
Scientific guideline: Draft concept paper on gu... [Published EMA Ongoing public consultations - Aug 01 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.